Rationale and indications for the use of alpha-keto analogues.
D000596:Amino Acids / Q000627:therapeutic use*; D000597:Amino Acids, Branched-Chain / Q000378:metabolism / Q000627:therapeutic use; D000601:Amino Acids, Essential / Q000378:metabolism; D000818:Animals; D004734:Energy Metabolism; D045782:Hemiterpenes; D006501:Hepatic Encephalopathy / Q000628:therapy; D006801:Humans; D007651:Keto Acids / Q000378:metabolism / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000628:therapy; D009136:Muscular Dystrophies / Q000235:genetics / Q000628:therapy
D000596:Amino Acids; D000597:Amino Acids, Branched-Chain; D000601:Amino Acids, Essential; D045782:Hemiterpenes; D007651:Keto Acids; C016211:alpha-keto-beta-methylvaleric acid; C001505:alpha-ketoisovalerate; C013082:alpha-ketoisocaproic acid